Importation of unregistered drugs for vital indications
Thanks to specific programs for the importation of drugs for vital indications, doctors and patients can access certain drugs that are not yet registered in a specific country, but are successfully used in other territories.
Local regulations, terminology (Managed Access Program, Expanded Access Program, Early Access Program) and legal requirements applicable to such programs may vary from country to country. However, all such programs are united by a single goal - to provide an opportunity for patients to benefit from novel and effective treatments.
COREX Logistics has extensive experience managing the processes necessary for these programs. We also recognize the growing demand access to unregistered drugs for patients suffering from life-threatening diseases. Our expert team offers full cycle solutions relating to the supply and importation of drugs in these circumstances. This includes managing all aspects involved including obtaining relevant permits and permissions for importation across our regions of operation, providing appropriate storage and transportation, gaining customs clearance and delivery of drugs.
Steps involved in importing unregistered drugs for specified health reasons:
Preparation of documentation
for obtaining an import license in accordance with the relevant regulatory requirements.
Obtaining permit for importation in a timely manner